Investor Presentation

6 November 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Revised Investor Presentation for the quarter and half-year ended 30 September 2026 Ref: Regulation 30 read-with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the captioned subject, please find enclosed the revised Management’s Presentation for the Earnings Conference Call with analysts/ Investors scheduled for 6 November 2026 in relation to the unaudited financial results (Standalone and Consolidated) for the quarter and half-year ended 30 September 2026. It is hereby informed that, due to an inadvertent typographical error, the workforce number mentioned in the earlier version of the presentation was incorrect. The same has been duly rectified in the revised presentation enclosed herewith. Kindly take the above-said information on record. Thank you, For Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331 Earnings Presentation Q2 & H1 FY27 Disclaimer Page title 24 pt 22 77 146 Page subtitle 20pt non bold • This presentation has been prepared by Aster DM Quality Care Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational 22 77 146 purposes only and are based on information regarding the Company and the economic, regulatory, market and other conditions as in effect on the date hereof. Subsequent Heading developments may impact the information contained in this presentation, which neither the Company nor its advisors or representatives are under an obligation to update, revise Font color –22 77 146 or affirm. Contents in the Presentation do not constitute or form part of an offer or invitation for sale or subscription of or solicitation or invitation of any offer to buy or subscribe Line: 22 77 146 for any securities, nor shall it or any part of it form the basis of or be relied on in connection with any contract, commitment or investment decision in relation thereto in India, the Excel color scheme United States or any other jurisdiction. A1: 22 77 146 A2: 129 129 129 • Prospective and existing investors should make their own evaluation of the Company as the information provided here does not purport to be all inclusive or to contain all of the A3: 0 180 141 information a prospective or existing investor may desire. Interested parties shall conduct their own due diligence and investigation on the information, before relying and acting thereon. Company makes no representation or warranty as to the accuracy or completeness of this information and shall not have any liability for any representations (expressed A4: 0 72 57 or implied) regarding information contained in, or for any omissions from, this information or any other written or oral communications transmitted to the recipient in the course A5: 74 144 228 of its evaluation of the Company. A6: 148 176 200 A7: 206 231 254 • This presentation may contain certain "forward looking statements", which are based on certain assumptions and expectations of future events. Actual future performance, A8: 218 219 221 outcomes and results may differ materially from those expressed in forward‐looking statements as a result of a number of risks, uncertainties and assumptions. Though such forward‐looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met. Neither the Company nor any of its advisors or For client representatives assumes any responsibility to update forward-looking statements or to adapt them to future events or developments. A1: 22 77 146 For CS Note - Q2 FY27 figures are based on the Limited Review of Aster DM Quality Care Limited’s results. Comparative figures for Q2 FY26 are presented on a pro forma basis, combining A3: 0 180 141 Aster’s financial information, which was based on limited review, with QCIL’s pro forma financial information. Highlight in tables H1: 218 219 221 H2: 188 208 222 Page title 24 pt 100 Days 22 77 146 Page subtitle 20pt non bold Together 22 77 146 Heading #GoGreater Font color – 22 77 146 Line: 22 77 146 One Team One Culture Excel color scheme One team across Aster, CARE, A1: 22 77 146 Evercare and KIMSHEALTH A2: 129 129 129 A3: 0 180 141 A4: 0 72 57 A5: 74 144 228 A6: 148 176 200 A7: 206 231 254 A8: 218 219 221 For client A1: 22 77 146 For CS A3: 0 180 141 Highlight in tables H1: 218 219 221 H2: 188 208 222 Page title 24 pt 22 77 146 Since 1 July 2026 Page subtitle 20pt non bold of surveyed employees feel energised by 100 Days 22 77 146 GO GREATER High engagement across clusters, functions and tenure Heading Together Font color – 22 77 146 Line: 22 77 146 Building one organisation under #GoGreater 2.2 mn1 18 50+ Excel color scheme A1: 22 77 146 Patients served Culture engagements Townhalls conducted together with every employee across units and offices A2: 129 129 129 A3: 0 180 141 A4: 0 72 57 Building One Unified Team Strengthening Leadership & Governance A5: 74 144 228 One Team Respect & Compassion Growth Ethics A6: 148 176 200 • Leadership strategy meet across the • Group leaders in place across finance, A7: 206 231 254 organisation operations, people, clinical and digital A8: 218 219 221 • Festivals and Day 1 celebrated as one family For client A1: 22 77 146 Integration & Clinical Synergies Zero Disruption Excellence Trusted Patient Care Accountability Agility For CS • Zero disruptions on patient care since Day 1 of A3: 0 180 141 • Clinical know-how shared across networks; integration Aster CMI expertise helped CARE Banjara • Early gains from collaboration have started Highlight in tables perform adaptive deep brain stimulation 8 shared tenets, cascaded through 18 culture flowing through engagements across all four brands H1: 218 219 221 H2: 188 208 222 1. 1. During the Quarter Highest Revenue, Op EBITDA and Margin in the First Quarter of the Merger Page title 24 pt 22 77 146 Page subtitle 20pt non bold 2,829 678 24.0 281 22 77 146 INR Cr INR Cr % INR Cr Revenue Op EBITDA1 Op EBITDA margin Normalised PAT2 Heading +19% YoY growth +25% YoY growth +111 bps YoY +34% YoY; Margin 9.9% Font color – 22 77 146 Line: 22 77 146 1,200 Excel color scheme Sustained Growth Momentum 24.0% A1: 22 77 146 Strong growth since the merger announcement, 22.9% culminating in record revenue, operating EBITDA and A2: 129 129 129 1,000 21.9% margins in our first quarter as a combined entity. A3: 0 180 141 20.7% 22.2% 2,829 21.3% A4: 0 72 57 2,600 800 20.5% 2,382 2,366 2,361 A5: 74 144 228 678 2,156 A6: 148 176 200 2,002 576 600 545 A7: 206 231 254 A8: 218 219 221 For client A1: 22 77 146 For CS A3: 0 180 141 Highlight in tables Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q2 FY27 Q4 FY25 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q2 FY27 H1: 218 219 221 Revenue (in INR Cr) Op. EBITDA (in INR Cr), With Margin 1. 1. Operating EBITDA and Operating EBITDA% for Q2 FY27 excludes ESOP Cost, Variable O&M fee amounting & Other Expenses H2: 188 208 222 2. 2. Normalised PAT (Post NCI) for Q2 FY27 excludes exceptional expenses related to merger & share of loss of equity accounted investees. Well Positioned to Unlock Value through Synergies Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 INR 16.6 Cr of synergies realised in Q2 FY27 Heading Font color – 22 77 146 Line: 22 77 146 Academics, Nursing Excel color scheme Business KPI & & Talent Sharing Reporting Standardization A1: 22 77 146 A2: 129 129 129 Renewable Energy Savings Material Cost Optimization A3: 0 180 141 A4: 0 72 57 Full Synergy Potential International Medical Tourism/ Indirect Cost Optimisation A5: 74 144 228 TPA INR 200 Cr A6: 148 176 200 CAPEX Quality & A7: 206 2 [Showing first 8,000 characters — download PDF for full document]